{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T16:09:24Z","timestamp":1782058164768,"version":"3.54.5"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jto.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jtho.2022.11.007","type":"journal-article","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T20:38:50Z","timestamp":1668458330000},"page":"339-349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Prediction of Distant Metastases After Stereotactic Body Radiation Therapy for Early Stage NSCLC: Development and External Validation of a Multi-Institutional Model"],"prefix":"10.1016","volume":"18","author":[{"given":"Sarah J.","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh W.","family":"Meadows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy D.","family":"Shafman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cary P.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo J.W. L.","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Miccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Stahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond H.","family":"Mak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy H.","family":"Decker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4313-2754","authenticated-orcid":false,"given":"Benjamin H.","family":"Kann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtho.2022.11.007_bib1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.prro.2017.04.014","article-title":"Stereotactic body radiation therapy for early-stage non-small cell lung cancer: executive summary of an ASTRO evidence-based guideline","volume":"7","author":"Videtic","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.jtho.2022.11.007_bib2","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1200\/JCO.2008.21.5681","article-title":"Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy","volume":"27","author":"Baumann","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2022.11.007_bib3","doi-asserted-by":"crossref","first-page":"LMT01","DOI":"10.2217\/lmt-2018-0006","article-title":"SBRT for early stage lung cancer: outcomes from biopsy-proven and empirically treated lesions","volume":"7","author":"Wegner","year":"2018","journal-title":"Lung Cancer Manag"},{"issue":"suppl 3","key":"10.1016\/j.jtho.2022.11.007_bib4","doi-asserted-by":"crossref","first-page":"S468","DOI":"10.21037\/jtd.2018.01.130","article-title":"Combining radiation plus immunotherapy to improve systemic immune response","volume":"10","author":"Cushman","year":"2018","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.jtho.2022.11.007_bib5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.21037\/tlcr.2018.08.16","article-title":"Combining stereotactic body radiation therapy with immunotherapy: current data and future directions","volume":"8","author":"Lin","year":"2019","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.jtho.2022.11.007_bib6","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.radonc.2018.10.017","article-title":"Stereotactic body\u00a0radiotherapy with adjuvant systemic therapy for early-stage non-small cell lung carcinoma: a multi-institutional analysis","volume":"132","author":"Kann","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jtho.2022.11.007_bib7","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jtho.2018.11.018","article-title":"Adjuvant systemic therapy in patients with early-stage NSCLC treated with stereotactic body radiation therapy","volume":"14","author":"Ernani","year":"2019","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2022.11.007_bib8","unstructured":"ClinicalTrials.gov. SBRT with immunotherapy in early stage non-small cell lung cancer: tolerability and lung effects. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03383302. Accessed March 22, 2022."},{"key":"10.1016\/j.jtho.2022.11.007_bib9","unstructured":"ClinicalTrials.gov. Pembrolizumab after lung SBRT for medically inoperable early stage non-small cell lung cancer. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03574220. Accessed March 22, 2022."},{"key":"10.1016\/j.jtho.2022.11.007_bib10","unstructured":"ClinicalTrials.gov. Stereotactic body radiation therapy (SBRT) combined with avelumab (anti-PD-L1) for management of early stage non-small cell lung cancer (NSCLC). https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03050554. Accessed March 22, 2022."},{"key":"10.1016\/j.jtho.2022.11.007_bib11","unstructured":"ClinicalTrials.gov. Testing the addition of the drug atezolizumab to the usual radiation treatment for patients with early non-small cell lung cancer. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04214262. Accessed March 22, 2022."},{"key":"10.1016\/j.jtho.2022.11.007_bib12","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.lungcan.2019.02.023","article-title":"Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall survival: a National Cancer Database analysis","volume":"130","author":"Foster","year":"2019","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2022.11.007_bib13","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.1200\/JCO.2008.16.4855","article-title":"Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B","volume":"26","author":"Strauss","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2022.11.007_bib14","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1148\/radiol.2016151829","article-title":"Early-stage non\u2013small cell lung cancer: quantitative imaging characteristics of 18F fluorodeoxyglucose PET\/CT allow prediction of distant metastasis","volume":"281","author":"Wu","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.jtho.2022.11.007_bib15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.radonc.2012.04.019","article-title":"Stereotactic body radiotherapy (SBRT) for non-small cell lung cancer (NSCLC): is FDG-PET a predictor of outcome?","volume":"104","author":"Clarke","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jtho.2022.11.007_bib16","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijrobp.2019.09.037","article-title":"Predicting 5-year progression and survival outcomes for early stage non-small cell lung cancer treated with stereotactic ablative radiation therapy: development and validation of robust prognostic nomograms","volume":"106","author":"Kang","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jtho.2022.11.007_bib17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.thorsurg.2014.12.003","article-title":"National Comprehensive Cancer Network (NCCN) clinical practice guidelines for lung cancer screening","volume":"25","author":"Wood","year":"2015","journal-title":"Thorac Surg Clin"},{"key":"10.1016\/j.jtho.2022.11.007_bib18","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/bjs.9736","article-title":"Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD Statement","volume":"102","author":"Collins","year":"2015","journal-title":"Br J Surg"},{"key":"10.1016\/j.jtho.2022.11.007_bib19","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ijrobp.2021.01.008","article-title":"Understanding competing risks","volume":"110","author":"Basak","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jtho.2022.11.007_bib20","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/1759-7714.12782","article-title":"Survival rates after lobectomy versus sublobar resection for early-stage right middle lobe non-small cell lung cancer","volume":"9","author":"Lv","year":"2018","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.jtho.2022.11.007_bib21","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/jso.2930350404","article-title":"Prognosis after resection of non-small cell lung cancer of the right middle lobe","volume":"35","author":"Peleg","year":"1987","journal-title":"J\u00a0Surg Oncol"},{"issue":"suppl 3","key":"10.1016\/j.jtho.2022.11.007_bib22","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1097\/JTO.0b013e318074de34","article-title":"Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study","volume":"2","author":"Onishi","year":"2007","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2022.11.007_bib23","doi-asserted-by":"crossref","first-page":"610","DOI":"10.21037\/jtd.2018.01.02","article-title":"Editorial on \u201cLong-term survival outcome after postoperative recurrence of non-small cell lung cancer: who is \u2018cured\u2019 from postoperative recurrence?\u201d","volume":"10","author":"Pfannschmidt","year":"2018","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.jtho.2022.11.007_bib24","author":"Gerds"},{"key":"10.1016\/j.jtho.2022.11.007_bib25","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1002\/sim.6152","article-title":"Calibration plots for risk prediction models in the presence of competing risks","volume":"33","author":"Gerds","year":"2014","journal-title":"Stat Med"},{"key":"10.1016\/j.jtho.2022.11.007_bib26","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1001\/jamaoncol.2020.4232","article-title":"Association of survival with adjuvant chemotherapy among patients with early-stage non-small cell lung cancer with vs without high-risk clinicopathologic features","volume":"6","author":"Pathak","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jtho.2022.11.007_bib27","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.ejcts.2008.02.005","article-title":"Prognostic value of FDG uptake in early stage non-small cell lung cancer","volume":"33","author":"Hanin","year":"2008","journal-title":"Eur J Cardio Thorac Surg"},{"key":"10.1016\/j.jtho.2022.11.007_bib28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1748-717X-9-41","article-title":"Pretreatment SUVmax predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy","volume":"9","author":"Horne","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.jtho.2022.11.007_bib29","unstructured":"Ishwaran H. Fast unified random forests for survival, regression, and classification (RF-SRC), R package version 2.9.3. Vol. 2020. https:\/\/cran.r-project.org\/web\/packages\/randomForestSRC\/randomForestSRC.pdf. Accessed March 22, 2022."},{"key":"10.1016\/j.jtho.2022.11.007_bib30","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.285.7.914","article-title":"Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis","volume":"285","author":"Gould","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jtho.2022.11.007_bib31","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0169-5002(02)00221-0","article-title":"PET imaging in patients with bronchioloalveolar cell carcinoma","volume":"38","author":"Heyneman","year":"2002","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2022.11.007_bib32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.lungcan.2004.01.009","article-title":"Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images","volume":"45","author":"Nomori","year":"2004","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2022.11.007_bib33","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1200\/JCO.2016.67.9647","article-title":"Contemporary update of a multi-institutional predictive nomogram for salvage radiotherapy after radical prostatectomy","volume":"34","author":"Tendulkar","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2022.11.007_bib34","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ijrobp.2014.11.022","article-title":"Nomograms for prediction of outcome with or without adjuvant radiation therapy for patients with endometrial cancer: a pooled analysis of PORTEC-1 and PORTEC-2 trials","volume":"91","author":"Creutzberg","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jtho.2022.11.007_bib35","unstructured":"National Comprehensive Cancer Network. Non-small cell lung cancer. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/nscl.pdf. Accessed March 22, 2022."},{"key":"10.1016\/j.jtho.2022.11.007_bib36","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12967-017-1326-1","article-title":"Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer","volume":"15","author":"Tong","year":"2017","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.jtho.2022.11.007_bib37","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.21037\/jtd-21-98","article-title":"Clinicopathological models for predicting lymph node metastasis in patients with early-stage lung adenocarcinoma: the application of machine learning algorithms","volume":"13","author":"Chong","year":"2021","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.jtho.2022.11.007_bib38","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2147\/TCRM.S272748","article-title":"Development and validation of a novel nomogram for predicting tumor-distant-metastasis in patients with early T1-2 stage lung adenocarcinoma","volume":"16","author":"Gu","year":"2020","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.jtho.2022.11.007_bib39","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0167-8140(97)00215-6","article-title":"Tumor volume: a basic and specific response predictor in radiotherapy","volume":"47","author":"Dubben","year":"1998","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jtho.2022.11.007_bib40","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.ijrobp.2007.07.2323","article-title":"Tumor volume combined with number of positive lymph node stations is a more important prognostic factor than TNM stage for survival of non-small-cell lung cancer patients treated with (chemo)radiotherapy","volume":"70","author":"Dehing-Oberije","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jtho.2022.11.007_bib41","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.7822","article-title":"Relationship between tumor size and metastatic site in patients with stage IV non-small cell lung cancer: a large SEER-based study","volume":"7","author":"Shan","year":"2019","journal-title":"PeerJ"},{"key":"10.1016\/j.jtho.2022.11.007_bib42","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jtcvs.2004.11.007","article-title":"The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival","volume":"130","author":"Cerfolio","year":"2005","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"suppl 58","key":"10.1016\/j.jtho.2022.11.007_bib43","first-page":"344","article-title":"The affect of the metabolic activity of the primary tumor to lymph node and distant metastasis in non-small cell lung cancer","volume":"44","author":"Yildirim","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jtho.2022.11.007_bib44","first-page":"1","article-title":"Lung cancer in young patients: higher rate of driver mutations and brain involvement, but better survival","volume":"5","author":"Suidan","year":"2019","journal-title":"J\u00a0Glob Oncol"},{"key":"10.1016\/j.jtho.2022.11.007_bib45","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1590\/1414-431x20144137","article-title":"Predictive significance of standardized uptake value parameters of FDG-PET in patients with non-small cell lung carcinoma","volume":"48","author":"Duan","year":"2015","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.jtho.2022.11.007_bib46","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5306\/wjco.v12.i4.217","article-title":"Oncogenic driver mutations in non-small cell lung cancer: past, present and future","volume":"12","author":"Chevallier","year":"2021","journal-title":"World J Clin Oncol"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086422019098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086422019098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:51:44Z","timestamp":1761562304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086422019098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1556086422019098"],"URL":"https:\/\/doi.org\/10.1016\/j.jtho.2022.11.007","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of Distant Metastases After Stereotactic Body Radiation Therapy for Early Stage NSCLC: Development and External Validation of a Multi-Institutional Model","name":"articletitle","label":"Article Title"},{"value":"Journal of Thoracic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtho.2022.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Association for the Study of Lung Cancer. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}